Clostridioides difficile Infection Prevention and Recovery Protocol
Primary Stack
Core supplements with strongest evidenceYeast probiotic that reduces C. difficile recurrence; survives antibiotics; produces anti-toxin protease
Restore healthy gut microbiome; competitive exclusion of C. difficile; support colonization resistance
Supporting Stack
Additional supplements for enhanced resultsSupports immune function; deficiency associated with C. difficile risk and severity
Supports immune function and gut barrier integrity; may reduce infection severity
Supporting Studies (1)
Supports intestinal barrier function and gut mucosal health
Supporting Studies (1)
Feeds beneficial gut bacteria; supports microbiome recovery after antibiotics
Supporting Studies (1)
Contains immunoglobulins; may help neutralize C. difficile toxins
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Clostridioides difficile (C. diff) is a bacterium that causes severe diarrhea and colitis, primarily in people who have recently taken antibiotics. Antibiotics disrupt the normal gut microbiome, allowing C. diff to overgrow and produce toxins that damage the intestinal lining. Symptoms range from mild diarrhea to severe, life-threatening colitis. Recurrence is common (20-30% after first episode).
CRITICAL: C. difficile infection requires medical treatment. Mild-moderate cases are treated with vancomycin or fidaxomicin antibiotics. Severe cases may require hospitalization, IV fluids, and sometimes surgery for fulminant colitis. Stop the causative antibiotic if possible. These supplements support prevention and recovery but are NOT treatments for active infection. If you have severe diarrhea, fever, abdominal pain, or bloody stool, seek medical care immediately.
PREVENTION IS KEY:
* Saccharomyces boulardii is a yeast probiotic with the strongest evidence for preventing C. diff. It survives antibiotics (unlike bacterial probiotics) and produces enzymes that break down C. diff toxins. Meta-analyses show significant reduction in C. diff infections.
* Lactobacillus and Bifidobacterium probiotics help restore the normal gut microbiome and provide "colonization resistance" against C. diff.
* Vitamin D deficiency is associated with increased C. diff risk and severity.
* Prebiotics (fiber) feed beneficial bacteria and support microbiome recovery.
* Glutamine supports the gut barrier.
For recurrent C. diff: Fecal microbiota transplant (FMT) is highly effective (>90% cure rate) and increasingly available. Discuss with your gastroenterologist.
Expected timeline: Probiotics should be started with antibiotics and continued for at least 2-4 weeks after. Full microbiome recovery can take months.
Clinical Perspective
Clostridioides difficile infection (CDI): toxin-mediated colitis. Risk factors: antibiotics (especially clindamycin, fluoroquinolones, cephalosporins), age >65, hospitalization, PPI use, immunosuppression. Classification: non-severe (WBC <15,000, Cr <1.5), severe (WBC ≥15,000 or Cr ≥1.5), fulminant (hypotension, ileus, megacolon). Diagnosis: stool PCR or toxin EIA.
CRITICAL: Treatment per IDSA guidelines: Non-severe - fidaxomicin 200mg BID or vancomycin 125mg QID x 10 days (fidaxomicin preferred - less recurrence); Severe - same; Fulminant - vancomycin 500mg QID PO/NG + IV metronidazole 500mg TID; consider surgery for megacolon/perforation. Stop inciting antibiotic if possible. Recurrence: 1st recurrence - fidaxomicin or extended vancomycin taper; 2nd+ recurrence - FMT (>90% effective). Supplements are PREVENTIVE and SUPPORTIVE.
* Saccharomyces boulardii (A-grade): Strongest evidence. Meta-analysis: prevention (PMID: 28771751). Cochrane: (PMID: 27631586). 250-500mg BID. Produces protease that cleaves toxin A/B. Safe with antibiotics.
* Lactobacillus/Bifidobacterium (A-grade): Microbiome restoration. Cochrane: (PMID: 27631586). Systematic review: recurrence (PMID: 28957757). 20-50 billion CFU daily. LGG and L. rhamnosus well-studied.
* Vitamin D (B-grade): Deficiency increases risk/severity. Systematic review: (PMID: 26657345). 2000-4000 IU daily.
* Zinc (C-grade): Immune support. Review: (PMID: 26040739). 15-30mg daily.
* Glutamine (C-grade): Gut barrier. Review: (PMID: 20357408). 5-10g daily.
* Prebiotics (B-grade): Microbiome support. Systematic review: (PMID: 27383068). 5-10g daily.
* Colostrum (C-grade): Anti-toxin immunoglobulins. Pilot: (PMID: 11780813). 1-3g daily.
Assessment targets: Stool frequency, abdominal symptoms, WBC, creatinine, albumin (severe), imaging if fulminant suspected.
Protocol notes: Probiotics timing: start same day as antibiotics; continue 2-4 weeks after completing antibiotics. Which probiotic: S. boulardii ideal because yeast not killed by antibacterial antibiotics; multi-strain Lactobacillus/Bifidobacterium also effective. Critically ill/immunocompromised: some caution with probiotics (rare fungemia with S. boulardii, bacteremia with Lactobacillus) - discuss with physician. PPIs: associated with CDI; discontinue if not essential. Hand hygiene: soap and water, NOT alcohol sanitizers (spores resistant). Contact precautions: until diarrhea resolves. Don't test for cure: stool may remain PCR-positive despite clinical cure. FMT: highly effective for recurrence; FDA-approved microbiome therapeutics now available (Rebyota, Vowst). Bezlotoxumab: monoclonal antibody against toxin B; reduces recurrence; consider for high-risk patients. Metronidazole: no longer first-line (inferior to vancomycin). Diet during recovery: bland, avoid lactose initially, gradual reintroduction; fermented foods support microbiome. Long-term: microbiome may take months to normalize; continue probiotics; fiber supports recovery.